Alendronate induces antinociception in mice, not related with its effects in bone

Japanese Journal of Pharmacology

Volumn 79, Issue 4, 1999, Pages 433-437

  Goicoechea, Carlos ^a   Porras, Esther ^a   Alfaro, María José ^a   Martín, Maria Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acetic acid test; Alendronate; Formalin test; Pain; Rodent

Indexed keywords

ACETIC ACID; ALENDRONIC ACID; FORMALDEHYDE; MORPHINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RAT;

EID: 0032927567     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.79.433     Document Type: Article

References (16)

1. Diener K: Bisphosphonates for controlling pain from metastatic bone disease. Am J Health Syst Pharm 53, 1917-1927 (1996)
2. Meunier PJ, Alexandre C, Edouard C, Mathieu L, Chapuy MC, Bressot C, Vignon E and Trechsel U : Effects of disodium dichloropethylene diphosphonate on Paget's disease of bone. Lancet 8141, 489-492 (1979)
3. Raisz LG: New diphosphonates to block bone resorption. N Engl J Med 302, 347-348 (1980)
4. Watts NB, Harris ST, Genat HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B and Chesnut CH : Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323, 73-79 (1990)
5. Adami S: Bisphosphonates in prostate carcinoma. Cancer 80, 1674-1679(1997)
6. Adami S, Fossaluzza V, Gatti D, Fracassi E and Braga V: Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Ann Rheum Dis 56, 201-204 (1997)
7. Fleish H: Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42, 919-944 (1991)
8. Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R and Lo Cascio V: The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypecalcemia of malignancy. Bone Miner 2, 395-404 (1987)
9. Lanza F, Rack MF, Simon TJ, Lombardi A, Reyes R and Suryawanshi S: Effects of alendronate on gastric and duodenal mucosa. Am J Gastroenterol 93, 753-757 (1998)
10. Allan E: Calcitonin in the treatment of intractable pain from advanced malignancy. Pharmatherapeutica 3, 482-486 (1983)
11. Szanto J, Ady N and Jozsef S : Pain killing with calcitonin nasal spray in patients with malignant tumours. Oncology 49, 180-182 (1992)
12. Jaeger H and Maier C: Calcitonin in phantom limb pain: a double-blind study. Pain 48, 21-27 (1992)
13. Martín MI, Goicoechea C, Colado MI and Alfaro MJ: Analgesic effect of salmon-calcitonin administered by two routes. Effect on morphine analgesia. Eur J Pharmacol 224, 77-82 (1992)
14. Hayashi G and Takemori AE : The type of analgesic-receptor interaction involved in certain analgesic assays. Eur J Pharmacol 16, 63-66 (1971)
15. Wheeler-Aceto H and Cowan A : Standarization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berl) 104, 35-44 (1991)
16. Dubuisson D and Dennis SG: The formalin test : a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4, 161 -174 (1979)